Pregnancy outcome in women exposed to antiepileptic drugs: Teratogenic role of maternal epilepsy and its pharmacologic treatment

Reproductive Toxicology

Volumn 39, Issue , 2013, Pages 50-57

  Cassina, Matteo ^a   Dilaghi, Arianna ^b   Di Gianantonio, Elena ^a   Cesari, Elena ^c   De Santis, Marco ^c   Mannaioni, Guido ^d   Pistelli, Alessandra ^b   Clementi, Maurizio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antiepileptic drugs; Birth defects; Epilepsy; Pregnancy; Teratogenicity

Indexed keywords

ANTICONVULSIVE AGENT; BARBEXACLONE; BUXAMINE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ANTICONVULSANT THERAPY; ANXIETY DISORDER; ARTICLE; BIRTH DEFECT; CHROMOSOME ABERRATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEPRESSION; EATING DISORDER; EPILEPSY; FEMALE; FETUS; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MICROCEPHALY; MONOTHERAPY; MOOD DISORDER; NEUROPATHIC PAIN; NEWBORN; PREGNANCY OUTCOME; PREGNANT WOMAN; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SPONTANEOUS ABORTION; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; INFANT, NEWBORN; ITALY; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84877316418     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.04.002     Document Type: Article

References (35)

1. Meador K., Reynolds M.W., Crean S., Fahrbach K., Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Research 2008, 81:1-13.
2. Harden C.L., Hopp J., Ting T.Y., Pennell P.B., French J.A., Allen Hauser W., et al. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009, 50:1229-1236.
3. Harden C.L., Meador K.J., Pennell P.B., Hauser W.A., Gronseth G.S., French J.A., et al. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009, 50:1237-1246.
4. Meador K.J., Baker G.A., Browning N., Clayton-Smith J., Combs-Cantrell D.T., Cohen M., et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. New England Journal of Medicine 2009, 360:1597-1605.
5. Meadow S.R. Anticonvulsant drugs and congenital abnormalities. Lancet 1968, 2:1296.
6. Laine-Cessac P., Le Jaoen S., Rosenau L., Gamelin L., Allain P., Grosieux P. Uncontrolled retrospective study of 75 pregnancies in women treated for epilepsy. Journal de gynecologie, obstetrique et biologie de la reproduction (Paris) 1995, 24:537-542.
7. Crawford P. Epilepsy and pregnancy: good management reduces the risks. Professional Care of Mother and Child 1997, 7:17-18.
8. Perucca E. Birth defects after prenatal exposure to antiepileptic drugs. The Lancet Neurology 2005, 4:781-786.
9. Bromfield E.B., Dworetzky B.A., Wyszynski D.F., Smith C.R., Baldwin E.J., Holmes L.B. Valproate teratogenicity and epilepsy syndrome. Epilepsia 2008, 49:2122-2124.
10. Veiby G., Daltveit A.K., Engelsen B.A., Gilhus N.E. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia 2009, 50:2130-2139.
11. Goodwin F.K., Goldstein M.A. Optimizing lithium treatment in bipolar disorder: a review of the literature and clinical recommendations. Journal of Psychiatric Practice 2003, 9:333-343.
12. Tomson T., Battino D., Bonizzoni E., Craig J., Lindhout D., Sabers A., et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. The Lancet Neurology 2011, 10:609-617.
13. Jentink J., Loane M.A., Dolk H., Barisic I., Garne E., Morris J.K., et al. Valproic acid monotherapy in pregnancy and major congenital malformations. New England Journal Medicine 2010, 362:2185-2193.
14. Aguglia U., Barboni G., Battino D., Cavazzuti G.B., Citernesi A., Corosu R., et al. Italian consensus conference on epilepsy and pregnancy, labor and puerperium. Epilepsia 2009, 50(Suppl. 1):7-23.
15. Clementi M., Di Gianantonio E., Ornoy A. Teratology information services in Europe and their contribution to the prevention of congenital anomalies. Community Genetics 2002, 5:8-12.
16. Schaefer C., Ornoy A., Clementi M., Meister R., Weber-Schoendorfer C. Using observational cohort data for studying drug effects on pregnancy outcome - methodological considerations. Reproductive Toxicology 2008, 26:36-41.
17. Bertino E., Spada E., Occhi L., Coscia A., Giuliani F., Gagliardi L., et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. Journal of Pediatric Gastroenterology and Nutrition 2010, 51:353-361.
18. Meister R., Schaefer C. Statistical methods for estimating the probability of spontaneous abortion in observational studies - analyzing pregnancies exposed to coumarin derivatives. Reproductive Toxicology 2008, 26:31-35.
19. Bangalore S., Messerli F.H. Of statistical significance: trends toward significance and optimism bias. Journal of the American College of Cardiology 2006, 48:1471. [author reply 1471].
20. Kalviainen R., Tomson T. Optimizing treatment of epilepsy during pregnancy. Neurology 2006, 67:S59-S63.
21. Meador K.J., Baker G.A., Finnell R.H., Kalayjian L.A., Liporace J.D., Loring D.W., et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology 2006, 67:407-412.
22. Holmes L.B., Hernandez-Diaz S. Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Research. Part A, Clinical and Molecular Teratology 2012, 94:599-606.
23. Moore J.L., Aggarwal P. Lamotrigine use in pregnancy. Expert Opinion on Pharmacotherapy 2012, 13:1213-1216.
24. Malm H., Artama M., Gissler M., Ritvanen A. Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstetrics & Gynecology 2011, 118:111-120.
25. Matok I., Pupco A., Koren G. Drug exposure in pregnancy and heart defects. Journal of Cardiovascular Pharmacology 2011, 58:20-24.
26. Mastroiacovo P., Leoncini E. More folic acid, the five questions: why, who, when, how much, and how. Biofactors 2011, 37:272-279.
27. Czeizel A.E., Timar L., Sarkozi A. Dose-dependent effect of folic acid on the prevention of orofacial clefts. Pediatrics 1999, 104:e66.
28. Wald N.J., Law M.R., Morris J.K., Wald D.S. Quantifying the effect of folic acid. Lancet 2001, 358:2069-2073.
29. Botto L.D., Olney R.S., Erickson J.D. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 2004, 125C:12-21.
30. Di Gianantonio E., Schaefer C., Mastroiacovo P.P., Cournot M.P., Benedicenti F., Reuvers M., et al. Adverse effects of prenatal methimazole exposure. Teratology 2001, 64:262-266.
31. De Santis M., Di Gianantonio E., Cesari E., Ambrosini G., Straface G., Clementi M. First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy. Drug Safety 2009, 32:239-244.
32. Cassina M., De Santis M., Cesari E., van Eijkeren M., Berkovitch M., Eleftheriou G., et al. First trimester diclofenac exposure and pregnancy outcome. Reproductive Toxicology 2010, 30:401-404.
33. Diav-Citrin O., Shechtman S., Halberstadt Y., Finkel-Pekarsky V., Wajnberg R., Arnon J., et al. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reproductive Toxicology 2011, 31:540-545.
34. Tomson T., Perucca E., Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 2004, 45:1171-1175.
35. Polifka J.E., Friedman J.M. Medical genetics: 1. Clinical teratology in the age of genomics. Canadian Medical Association Journal 2002, 167:265-273.